GeoSequence
Objectivity
in a subjective world
Optimal launch sequencing is essential to achieving peak sales for any global product. Yet the planning process is often subjective, qualitative, disparate and ad hoc.
GeoSequence’s current data and advanced analytics are crucial to optimized product planning and value in today’s complex global market.
How do countries rank in attractiveness relative to each other?
Which countries, when, and why to select and prioritize for new launches?
Where should I invest in geographic expansion and why?
What countries will deliver the most productive revenue, patient capture, new product uptake, etc.?
Who’s Hot, Who’s Hotter
Relative attractiveness of each product/country opportunity
Attractiveness Index:
Identifies multiple independent variables via credible, global data sources. The Optivara algorithm documents and indexes variables within each criteria, and overall, to create an Attractiveness Index for a specific product in each country of interest.
Prioritize product launches by country and region to capitalize on market dynamics in both developed and emerging countries.
Objectively define attractiveness of potential acquisitions, partnerships and products.
Capitalize on the power of “global data” and Optivara’s ability to collect and display data in an intuitive, integrated application.
Volume
Country’s capacity for consuming healthcare
Burden
Scope of the targeted disease in the country
Access
Potential for the population to afford and obtain the product(s)
Ease
Ease of doing business in the country and providing a new Rx to patients in need
Pretium
Expected ability to realize revenue potential based on a country’s approach to pricing
It’s Always Go Time
Make informative decisions along development stages
Prediction on the Fly
The best models incorporate both quantitative analytics and qualitative insights. Global launch sequencing is a complex task requiring input from corporate stakeholders to global affiliate offices. Organizations often struggle with creating a standard by which they can identify and rank opportunities that exist beyond the top 10, or tier 1, countries.
Using global data, and leveraging internal expertise, GeoSequence strategically addresses country-level challenges and creates an adaptable model for organizational excellence. As the market evolves and more data become available, GeoSequence fine-tunes scenarios to minimize costly delays and ensure maximum profitability.
Phase 1
Determine country attractiveness for regulatory filings, clinical trial coverage, and country fit.
Phase 2
Define country and regional scope for regulatory filing and country information needs.
Beginning of Phase 3
Finalize country/regional scope for product filing and relevance for clinical trial information.
End of Phase 3
Finalize country launch order based on country readiness and investment requirements.
Optivara Speaks Success
Go world-wide with global data integration
Leading the Way
GeoSequence guides strategies for country preparedness, commercial infrastructure investment, in-and out-licensing, sales and marketing collaborations, and opportunity forecasting.
Powerful Combination
Global data integration, proprietary analytics, and meaningful visualizations and dashboards combine to provide real-time evidence-based answers to critical business questions.
Are You Ready to GeoSequence?
Many clients know their top 10 launch countries, but what about the rest of the world?